Synthesis, characterization and evaluation of in vitro anticancer potential of novel fluorinated 5-benzylidene-3-ethyl-2-(2-methyl-3-trifluoromethyl-phenylimino)thiazolidin-4-one derivatives: Comparison of reflux and ultrasonic conditions for Knoevenagel reaction

被引:0
作者
Kadam, Shreyash D. [1 ]
Mammen, Denni [1 ]
Nikam, Laxmikant B. [2 ]
Bagul, Rahul R. [3 ]
机构
[1] Navrachana Univ, Sch Sci, Vasana Bhayli Rd, Vadodara 391410, Gujarat, India
[2] Bharat Rasayan Ltd, 1421,MIE Part B, Bhardurgarh 124507, Haryana, India
[3] Gujarat Fluorochem Ltd, Panchmahal 389380, Gujarat, India
来源
INDIAN JOURNAL OF CHEMISTRY | 2024年 / 63卷 / 11期
关键词
Fluorine; Thiazolidin-4-one; Knoevenagel reaction; Ultrasonic waves; Anticancer activity; Hep-G2 cell line; BIOLOGICAL EVALUATION; CYTOTOXICITY; THIAZOLIDINONE; 4-THIAZOLIDINONES; TOXICITY; ISCHEMIA; CP-060S; AGENTS; ASSAY;
D O I
10.56042/ijc.v63i11.11976
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A set of novel 5-benzylidene-3-ethyl-2-(2-methyl-3-trifluoromethyl-phenylimino)-thiazolidin-4-one derivatives have been synthesized by Knoevenagel reaction via both conventional as well as non-conventional methods on the synthesized iminothiazolidinone core. In terms of yield and reaction time, the ultrasound mediated Knoevenagel reaction method has proved to be more effective than the conventional approach using heat. The H-1 NMR spectra have been used to deduce the structure of the compounds, while LC-MS, FTIR, and elemental analysis data have also been utilized for better confirmation. Using a 2D NOESY NMR experiment, the stereochemistry of the final compound has been verified. The synthesized benzylidine compounds have been screened for in vitro anticancer potential against Human Hepatoma (Hep-G2) cell line. The compound having p-substituted methoxy group on benzylidine moiety is observed to be the most active against the tested cell line as compared to the rest of the compounds.
引用
收藏
页码:1102 / 1111
页数:10
相关论文
共 57 条
  • [1] Synthesis, Anti-Diabetic and Renoprotective Activity of Some New Benzazole, Thiazolidin-4-one and Azetidin-2-one Derivatives
    Abeed, Ahmed Abdou O.
    Youssef, Mohamed Salah K.
    Hegazy, Rehab
    [J]. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2017, 28 (11) : 2054 - 2063
  • [2] Abhinir M., 2009, Int J Pharm Pharm Sei, P47
  • [3] The anti-ischemic effects of CP-060S during pacing-induced ischemia in anesthetized dogs
    Adachi, Y
    Suzuki, Y
    Homma, N
    Fukazawa, M
    Tamura, K
    Nishie, I
    Kuromaru, O
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) : 267 - 273
  • [4] Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
    Bae, Jaehyun
    Park, Taegyun
    Kim, Hyeyoung
    Lee, Minyoung
    Cha, Bong-Soo
    [J]. DIABETES & METABOLISM JOURNAL, 2021, 45 (03) : 326 - 336
  • [5] Balfour JAB, 1999, DRUGS, V57, P921
  • [6] Harms from Increasingly Agentic Algorithmic Systems
    Chan, Alan
    Salganik, Rebecca
    Markelius, Alva
    Pang, Chris
    Rajkumar, Nitarshan
    Krasheninnikov, Dmitrii
    Langosco, Lauro
    He, Zhonghao
    Duan, Yawen
    Carroll, Micah
    Lin, Michelle
    Mayhew, Alex
    Collins, Katherine
    Molamohammadi, Maryam
    Burden, John
    Zhao, Wanru
    Rismani, Shalaleh
    Voudouris, Konstantinos
    Bhatt, Umang
    Weller, Adrian
    Krueger, David
    Maharaj, Tegan
    [J]. PROCEEDINGS OF THE 6TH ACM CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, FACCT 2023, 2023, : 651 - 666
  • [7] Synthesis and antimicrobial screening of 5-arylidene-2-imino-4-thiazolidinones
    Chavan, Ameya A.
    Pai, Nandini R.
    [J]. ARKIVOC, 2007, : 148 - 155
  • [8] PALLADATION OF DIMETHYLHYDRAZONES, OXIMES, AND OXIME O-ALLYL ETHERS - CRYSTAL-STRUCTURE OF [PD3(ON = CPRIPH)6]
    CONSTABLE, AG
    MCDONALD, WS
    SAWKINS, LC
    SHAW, BL
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1978, (23) : 1061 - 1062
  • [9] Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
    D'Ambrosio, Daniele
    Freedman, Mark S.
    Prinz, Joerg
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (01) : 18 - 33
  • [10] Deshmukh MB, 2008, INDIAN J CHEM B, V47, P792